Curis | CRIS - Ebitda





Ebitda Изменить Дата
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 1.97B 457M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Incyte USD 414.5M 92.42M 2025-12
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.3B 530M 2026-03
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Takeda JPY 448.13B 173.98B 2025-12
TG Therapeutics USD 32.69M 5M 2025-09
Xoma USD 2.52M 7.98M 2024-06